Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/09/2026 inter alia to consider and approve to consider discuss and decide various matters in connection with the Rights Issue including the specific terms of the Rights Issue such as the determination of the Rights Issue price and related payment mechanism rights entitlement ratio the record date and timing of the Rights Issue